Huppert, J; Closhen, D; Croxford, A et al.
Cellular mechanisms of IL-17-induced blood-brain barrier disruptionFASEB JOURNAL. Bd. 24. H. 4. 2010 S. 1023-1034
Moehler, M; Mueller, A; Trarbach, T et al.
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: A prospective multi-center biomarker-oriented phase II studyONKOLOGIE. Bd. 33. 2010 S. 116-116
Schimanski, CC; Moehler, M; Zimmermann, T et al.
Cetuximab-induced skin exanthema: Improvement by a reactive skin therapyMOLECULAR MEDICINE REPORTS. Bd. 3. H. 5. 2010 S. 789-793
Atreya, R; Neurath, MF
Chemokines in Inflammatory Bowel DiseasesDIGESTIVE DISEASES. Bd. 28. H. 3. 2010 S. 386-394
Seitz, SJ; Schleithoff, ES; Koch, A et al.
Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathwayINTERNATIONAL JOURNAL OF CANCER. Bd. 126. H. 9. 2010 S. 2049-2066
Kiesslich, R
Chromoendoscopy: What Is Its True Value for Ulcerative Colitis Surveillance?DIGESTIVE DISEASES. Bd. 28. H. 3. 2010 S. 445-451
Kiesslich, R; Goetz, M; Hoffman, A et al.
Chromoscopic Guided Endomicroscopy - A New Atraumatic Surveillance Option for Patients With Ureterosigmoidostomy or Rectosigmoid PouchGASTROINTESTINAL ENDOSCOPY. Bd. 71. H. 5. 2010 S. AB209-AB209
Kornek, M; Yoshida, S; Afdhal, NH et al.
CIRCULATING HUMAN T-CELL DERIVED MICROPARTICLES (MP): A NOVEL PLASMA MARKER OF HEPATIC INFLAMMATION IN PATIENTS WITH HEPATITIS CHEPATOLOGY. Bd. 52. H. 4. 2010 S. 1123A-1123A
Rey, JW; Bode, D; Wirges, U et al.
CLINICAL AND HISTOPATHOLOGICAL FINDINGS IN EXPLANTED BUT NOT TRANSPLANTED KIDNEYS - A RETROSPEKTIVE ANALYSISTRANSPLANT INTERNATIONAL. Bd. 23. 2010 S. 56-56
Krauss, E; Konturek, P; Maiss, J et al.
Clinical significance of lymphoid hyperplasia of the lower gastrointestinal tractENDOSCOPY. Bd. 42. H. 4. 2010 S. 334-337